+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Soft Double Aluminum Composite Film for Pharmaceutical Market by Application, End User, Layer Structure, Product Grade - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083006
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Soft double aluminum composite film is reshaping modern pharmaceutical packaging by offering advanced product protection and operational efficiency across global supply chains. This comprehensive market analysis equips executives with critical insight into the sector’s transformative drivers and competitive dynamics.

Market Snapshot of Soft Double Aluminum Composite Film

The soft double aluminum composite film market continues its robust growth trajectory, underpinned by industry-wide adoption of high-barrier materials to preserve sensitive drug formulations. Demand accelerates as pharmaceutical companies seek solutions enabling safe, compliant, and brand-differentiated delivery of biologics and specialty medications. Recent regulatory frameworks, combined with complex global logistics, ensure that packaging innovation remains a decisive differentiator for both established manufacturers and emerging entrants.

The sector’s expansion reflects the shift toward customized, sustainable, and technology-ready packaging. Evolving reimbursement models and shifting supply chains shape investment priorities, while product innovation and evolving end-user demands intensify the competitive landscape. Experienced leadership is essential for translating these macro trends into commercial success at scale.

Scope & Segmentation

  • Application: Over the Counter, Prescription
  • End User: Clinics, Hospitals, Retail Pharmacies
  • Layer Structure: Four Ply, Three Ply, Two Ply
  • Product Grade: Cold Formable, Heat Sealable
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: UACJ Corporation, Constantia Flexibles Group GmbH, Amcor plc, CCL Industries Inc., Mitsubishi Aluminum Co., Ltd., Essentra plc, Coveris Holdings S.A., Lotte Advanced Materials Co., Ltd., Uflex Limited, Klöckner Pentaplast Group

Within each segment, product grade and application drive differentiation, enabling tailored packaging for both consumer-friendly and compliance-focused pharmaceutical products. Technology investments—such as digital printing, enhanced barrier layering, and sustainable film engineering—further define competitive advantage across diverse regional markets.

Key Takeaways

  • Soft double aluminum composite film delivers robust barrier integrity, supporting strict regulatory needs and product performance through advanced moisture and oxygen control.
  • Increasing adoption of serialization and anti-counterfeiting features targets global challenges in drug safety, aligning packaging with compliance and supply chain transparency mandates.
  • Innovation in polymer blends and digital printing platforms enables rapid customization, allowing pharmaceutical providers to adapt packaging for novel therapies and localized campaigns.
  • Shift toward regional manufacturing and nearshoring is optimizing supply chains, addressing both logistics challenges and cost sensitivities resulting from evolving trade scenarios.
  • Layer structure significantly affects market positioning, with high-barrier, multi-ply formats serving critical roles in protecting advanced formulations and supporting automation in filling lines.

Tariff Impact: Strategic Response to U.S. Aluminum Packaging Tariffs

The introduction of U.S. tariffs on aluminum-based packaging in 2025 heightened cost pressure throughout the value chain. Supply resilience improved as companies diversified sourcing and accelerated nearshoring initiatives near key pharmaceutical clusters. Manufacturers responded with capital investment in new facilities and optimized composite film designs while aligning operational strategies to navigate regulatory shifts and contain upstream expense volatility.

Methodology & Data Sources

Our analysis utilizes a comprehensive methodology encompassing secondary data from industry-wide publications, regulatory documents, and peer-reviewed journals. Primary input was gathered through interviews with procurement executives, packaging engineers, and regulatory specialists across major regions to validate market trends. Findings were triangulated and reviewed by an expert panel to maintain accuracy and actionable relevance.

Why This Report Matters

  • Enables leaders to benchmark procurement and innovation strategies against market shifts and regulatory frameworks affecting pharmaceutical packaging.
  • Assists in identifying emerging material opportunities and technology investments to support regional and segment diversification.
  • Supports strategic supply chain planning and partnership development in response to evolving global trade dynamics and sustainability goals.

Conclusion

Senior decision-makers can leverage these insights to align product and process innovation with evolving market demands, regulatory expectations, and sustainability initiatives. The report delivers a strategic foundation for growth and resilience in pharmaceutical packaging markets globally.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Soft Double Aluminum Composite Film for Pharmaceutical Market, by Application
8.1. Introduction
8.2. Over The Counter
8.3. Prescription
9. Soft Double Aluminum Composite Film for Pharmaceutical Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Hospitals
9.4. Retail Pharmacies
10. Soft Double Aluminum Composite Film for Pharmaceutical Market, by Layer Structure
10.1. Introduction
10.2. Four Ply
10.3. Three Ply
10.4. Two Ply
11. Soft Double Aluminum Composite Film for Pharmaceutical Market, by Product Grade
11.1. Introduction
11.2. Cold Formable
11.3. Heat Sealable
12. Americas Soft Double Aluminum Composite Film for Pharmaceutical Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Soft Double Aluminum Composite Film for Pharmaceutical Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Soft Double Aluminum Composite Film for Pharmaceutical Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. UACJ Corporation
15.3.2. Constantia Flexibles Group GmbH
15.3.3. Amcor plc
15.3.4. CCL Industries Inc.
15.3.5. Mitsubishi Aluminum Co., Ltd.
15.3.6. Essentra plc
15.3.7. Coveris Holdings S.A.
15.3.8. Lotte Advanced Materials Co., Ltd.
15.3.9. Uflex Limited
15.3.10. Klöckner Pentaplast Group
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET MULTI-CURRENCY
FIGURE 2. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET MULTI-LANGUAGE
FIGURE 3. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY FOUR PLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY THREE PLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY TWO PLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COLD FORMABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY HEAT SEALABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. CANADA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 33. CANADA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED KINGDOM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED KINGDOM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED KINGDOM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 54. UNITED KINGDOM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 55. GERMANY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. GERMANY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GERMANY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 58. GERMANY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 59. FRANCE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FRANCE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. FRANCE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 63. RUSSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. RUSSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. RUSSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 66. RUSSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 67. ITALY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. ITALY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 70. ITALY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 71. SPAIN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. SPAIN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. SPAIN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 74. SPAIN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 75. UNITED ARAB EMIRATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED ARAB EMIRATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED ARAB EMIRATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 78. UNITED ARAB EMIRATES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 79. SAUDI ARABIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. SAUDI ARABIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. DENMARK SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. DENMARK SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 90. DENMARK SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 91. NETHERLANDS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. NETHERLANDS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. NETHERLANDS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 94. NETHERLANDS SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 95. QATAR SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. QATAR SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. QATAR SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 98. QATAR SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 99. FINLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. FINLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. FINLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 102. FINLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 103. SWEDEN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SWEDEN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SWEDEN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 106. SWEDEN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 111. EGYPT SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EGYPT SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 115. TURKEY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. TURKEY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. TURKEY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 118. TURKEY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 119. ISRAEL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ISRAEL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ISRAEL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 123. NORWAY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. NORWAY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. NORWAY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 126. NORWAY SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 127. POLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. POLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. POLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 130. POLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. CHINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. CHINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. CHINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 143. CHINA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 144. INDIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. INDIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. INDIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 147. INDIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 148. JAPAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. JAPAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 151. JAPAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 164. THAILAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. THAILAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. THAILAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 167. THAILAND SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TAIWAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY LAYER STRUCTURE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SIZE, BY PRODUCT GRADE, 2018-2030 (USD MILLION)
TABLE 188. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
TABLE 189. SOFT DOUBLE ALUMINUM COMPOSITE FILM FOR PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Soft Double Aluminum Composite Film for Pharmaceutical market report include:
  • UACJ Corporation
  • Constantia Flexibles Group GmbH
  • Amcor plc
  • CCL Industries Inc.
  • Mitsubishi Aluminum Co., Ltd.
  • Essentra plc
  • Coveris Holdings S.A.
  • Lotte Advanced Materials Co., Ltd.
  • Uflex Limited
  • Klöckner Pentaplast Group